CTT Pharmaceutical Holdings, Inc.
CTTH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.38M
Close$
$-0.00
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.38 Million |
|---|---|
| Enterprise Value | $3.40 Million |
| Earnings per Share | $0 |
| Beta | 0.72 |
| Outstanding Shares | 59,722,232 |
Return
| Return on Equity | -635.65% |
|---|---|
| Return on Assets | -245.49% |
| Return on Invested Capital | -496.52% |
Valuation & Multiples
| P/E Ratio | -43.54 |
|---|---|
| PEG | -39.79 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -26.29 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 17, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CTT Pharmaceutical Holdings, Inc.
1 employees
CEO: Ryan Khouri
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development...